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Toll-like receptors (TLRs) play a crucial role in the
onset of innate immunity by distinguishing between
endogenous and pathogen-associated molecular patterns.
TLR2, in cooperation with TLR1 and TLR6, recognizes
several microbial components such as lipoteichoic acids
and lipoproteins [1]. Toll-like receptors have been
broadly reported to contribute to several inflammatory
chronic diseases and autoimmune diseases [2]. In this
s t u d yw ea i mt od i s c o v e rn e wT L R 2m o d u l a t i n ga g e n t s
through computer-aided drug design.
Based on recently identified synthetic TLR2 agonists
[3] and antagonists [4], a shape and chemical-feature
based similarity search was performed against a library
of 260.071 compounds provided by the National Cancer
Institute (NCI) [5]. This led to several virtual hits, which
were tested in vitro in a cell-based assay. Several com-
pounds with biological activity on TLR2 signaling in
general and TLR1 signaling specifically were identified.
To further optimize these biologically validated virtual
hits, molecular interaction fields (MIFs) for the dimeri-
zation of TLR2 and TLR1 were developed. Feature-
based MIFs allowed for the manual creation of virtual
compounds that fulfill an optimized interaction pattern,
which led to a 3D pharmacophore that was used for a
second virtual screening to select compounds for biolo-
gical testing.
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